Percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market expansion is anticipated to be restrained by rising product recalls over the forecast period. For instance, in February 2020, Abbott, a medical device and healthcare company, voluntarily recalled specific lots of two types of its coronary angioplasty catheters (NC Trek RX Coronary Dilatation Catheter and NC Traveler Coronary Dilatation Catheter), as the balloons from the impacted lots may not deflect as intended, and the U.S Food and Drug Administration has classified this as a Class I recall.
The global market for Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon Catheters is projected to reach a value of 2.2 billion United States dollars in 2022 and is anticipated to expand at a compound annual growth rate of 8% over the period of forecast (2022-2030).
Leading Companies in the Percutaneous Transluminal Coronary Angioplasty Balloon Catheter Industry:
1 Cook Group
Cook GroupScientific was founded in 1963 and its Bloomington, Indiana, United States.The company operates in 135 countries.
2. Medtronic Plc
Medtronic Plc founded in 1949, and it’s located Dublin, Ireland. The Company operates in 150 Countries.
3. Dickinson and Company
Dickinson and Company, was launch in 1987 and it’s headquarter located Franklin Lakes, New Jersey, United States.it operate over 50 country and in 2022 Omega Laboratories ("Omega"), a leading provider of laboratory testing solutions, announced the acquisition of Acumium.